Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation

Clinical trial NCT01208961 · COMPLETED

Trial details

NCT number: NCT01208961
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Hypertriglyceridemia

Start date: 2010-09-01
Primary completion: 2010-11-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.